La Grotta R, de Candia P, Olivieri F, et al
A SARMOUNT-5 clinical study shows that Zepbound led to an average of 20.2% weight loss
However, most of these efforts have been plagued with significant adverse effects and/or limited efficacy which has resulted in the withdrawal and discontinued use for the majority of these medications [5]
Preclinical and translational research also positions Cagrilintide within investigations of adipose tissue biology, lipid metabolism signaling, and glucose homeostasis pathways, particularly in models examining multi-hormonal interactions and metabolic feedback mechanisms
And you may further rationalize, well if they do shut them down, at least they wont come after me
If you would like more prescribing information, please refer to the Patient Information Leaflet